ArticleJournal of orthopaedic surgery and research2025
LINC00341 promotes fracture healing through downregulation of miR-133a-3p.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MicroRNA networks associated with skeletal aging and WNT pathway modulation.Calcified tissue international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the role of LINC00341 in delayed fracture healing (DFH) and its regulatory mechanism through miR-133a-3p.
methodsThis study analyzed serum samples from 131 patients with tibial fractures, including 67 patients with normal fracture healing (NFH) and 64 with DFH. The levels of LINC00341, miR-133a-3p and osteogenic marker-related mRNAs were verified by RT-qPCR assays. Cell viability and apoptosis were detected by CCK-8 and flow cytometry. Dual-luciferase reporter and RNA immunoprecipitation (RIP) assays were performed to confirm the binding between LINC00341 and miR-133a-3p.
resultsThe expression of LINC00341 was found to be downregulated in DFH patients. This downregulation of LINC00341 inhibited the mRNA expression of osteogenic markers, reduced osteoblast viability, and increased apoptosis in MC3T3-E1 cells. Additionally, miR-133a-3p was identified as a target miRNA of LINC00341. Reducing miR-133a-3p effectively eliminated the negative impact of LINC00341 downregulation on osteoblast proliferation and differentiation.
conclusionLINC00341 enhances fracture healing by targeting miR-133a-3p, indicating its potential as a potential target for clinical diagnosis and therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.